The pilot-in-command of Air India flight AI 2379 [1] reportedly tested positive for psychoactive substances following a severe turbulence incident on Aug. 4 [2].
This development raises critical questions regarding cockpit safety and regulatory oversight, as the Directorate General of Civil Aviation (DGCA) investigates whether pilot impairment contributed to the flight's instability.
The incident occurred during a flight from Phuket, Thailand, to Delhi, India [3]. While traveling near the coast of Odisha, the aircraft encountered severe turbulence that caused the plane to drop 300 feet [2] mid-air [3].
Following the flight, two pilots were screened for controlled substances [1]. The results indicated that the pilot-in-command had psychoactive substances in his system [1]. The DGCA said it has ordered a confirmatory test to verify these initial findings [1].
Both pilots involved in the flight have been taken off duty while the investigation continues [1]. The DGCA said it is awaiting the final report to determine the exact nature of the substances found and the subsequent disciplinary actions required [1].
Air India has not provided a detailed public response to the specific test results, though reports indicate the airline is distancing itself from the controversy [3]. The DGCA said it maintains oversight of the process to ensure aviation safety standards were not compromised during the Phuket-Delhi route [1].
“The pilot-in-command reportedly tested positive for psychoactive substances in a post-flight dope test.”
This incident highlights the stringent nature of post-incident screening in aviation. If the confirmatory test remains positive, it could lead to permanent license revocation for the pilot and prompt the DGCA to review Air India's internal health and drug screening protocols to prevent future cockpit impairment.
